Aldeyra Therapeutics, Inc. (ALDX)
5.36
+0.11
(+2.10%)
USD |
NASDAQ |
Feb 13, 14:05
Aldeyra Therapeutics Free Cash Flow : -40.08M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Assertio Holdings, Inc. | 13.33M |
| MediciNova, Inc. | -9.728M |
| Altimmune, Inc. | -66.66M |
| Actinium Pharmaceuticals, Inc. | -25.04M |
| Avanos Medical, Inc. | 74.90M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.021M |
| Cash from Investing (Quarterly) | 25.00M |
| Cash from Financing (Quarterly) | 0.1207M |
| Free Cash Flow Per Share (Quarterly) | -0.1168 |
| Free Cash Flow to Equity (Quarterly) | -7.009M |
| Free Cash Flow to Firm (Quarterly) | -6.546M |
| Free Cash Flow Yield | -12.48% |